{
    "organizations": [],
    "uuid": "b2df01e861ee04d3844a0bfda672b85d194ab12c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-lilly-says-treatment-with-taltz-sh/brief-lilly-says-treatment-with-taltz-showed-improvement-in-impact-of-genital-psoriasis-on-sexual-activity-idUSFWN1Q9083",
    "ord_in_thread": 0,
    "title": "BRIEF-Lilly Says Treatment With Taltz Showed Improvement In Impact Of Genital Psoriasis On Sexual Activity",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 01 PM / in 22 minutes BRIEF-Lilly Says Treatment With Taltz Showed Improvement In Impact Of Genital Psoriasis On Sexual Activity Reuters Staff 1 Min Read Feb 19 (Reuters) - Eli Lilly And Co: * AAD 2018: TREATMENT WITH LILLYâ€˜S TALTZ (IXEKIZUMAB) RESULTED IN IMPROVEMENT IN IMPACT OF GENITAL PSORIASIS ON SEXUAL ACTIVITY * ELI LILLY-PATIENTS WITH MODERATE-TO-SEVERE GENITAL PSORIASIS TREATED WITH TALTZ SAW LOWER IMPACT OF CONDITION ON SEXUAL ACTIVITY VERSUS PLACEBO POST 12-WK TREATMENT Source text for Eikon: Further company coverage:",
    "published": "2018-02-19T13:58:00.000+02:00",
    "crawled": "2018-02-19T14:14:12.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "say",
        "treatment",
        "taltz",
        "showed",
        "improvement",
        "impact",
        "genital",
        "psoriasis",
        "sexual",
        "activity",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "eli",
        "lilly",
        "co",
        "aad",
        "treatment",
        "lilly",
        "taltz",
        "ixekizumab",
        "resulted",
        "improvement",
        "impact",
        "genital",
        "psoriasis",
        "sexual",
        "activity",
        "eli",
        "genital",
        "psoriasis",
        "treated",
        "taltz",
        "saw",
        "lower",
        "impact",
        "condition",
        "sexual",
        "activity",
        "versus",
        "placebo",
        "post",
        "treatment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}